Scilex Holding (SCLXW) Free Cash Flow (2020 - 2026)

Scilex Holding (SCLXW) recorded quarterly Free Cash Flow of $900000.0 in Q1 2026, up 105.15% quarter-over-quarter from -$17.5 million in Q4 2025, and down 85.02% on a YoY basis from $6.0 million in Q1 2025.

Scilex Holding (SCLXW) Free Cash Flow (2020 - 2026) Analysis & Trends

Scilex Holding's Free Cash Flow history runs 7 years deep, the most recent figure standing at $900000.0 for Q1 2026.

  • In Q1 2026, Free Cash Flow fell 85.02% year-over-year to $900000.0; the TTM figure through Mar 2026 stood at -$1.3 million (down 108.09% YoY), while the FY2025 annual figure was $3.7 million, down 80.97% from the prior year.
  • Free Cash Flow was $900000.0 for Q1 2026 at Scilex Holding, up from -$17.5 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $9.4 million in Q1 2024 to a low of -$17.5 million in Q4 2025.
  • Historically, Free Cash Flow has averaged -$1.1 million across 5 years, with a median of $2.3 million in 2024.
  • Biggest YoY gain for Free Cash Flow was 1879.14% in 2022; the steepest drop was 2136.1% in 2022.
  • A 5-year view of Free Cash Flow shows it stood at -$725000.0 in 2022, then plunged by 643.59% to -$5.4 million in 2023, then soared by 147.0% to $2.5 million in 2024, then plunged by 789.46% to -$17.5 million in 2025, then surged by 105.15% to $900000.0 in 2026.
  • The last three Free Cash Flow figures came in at $900000.0 (Q1 2026), -$17.5 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 2.12 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 3.01 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 1.47 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 3.56 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 2.93 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 1.48 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 2.43 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 2.18 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 757.00 Mn
10 Scilex Holding - - 4.15 Mn 900,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 900,000.00
Mar 31, 2026 900,000.00
Dec 31, 2025 -17.47 Mn
Dec 31, 2025 -17.47 Mn
Sep 30, 2025 8.19 Mn
Sep 30, 2025 8.19 Mn
Jun 30, 2025 7.09 Mn
Jun 30, 2025 7.09 Mn
Mar 31, 2025 6.01 Mn
Mar 31, 2025 6.01 Mn
Dec 31, 2024 2.53 Mn
Dec 31, 2024 2.53 Mn
Sep 30, 2024 5.11 Mn
Sep 30, 2024 5.11 Mn
Jun 30, 2024 2.31 Mn
Jun 30, 2024 2.31 Mn
Mar 31, 2024 9.39 Mn
Mar 31, 2024 9.39 Mn
Dec 31, 2023 -5.39 Mn
Dec 31, 2023 -5.39 Mn